VANCOUVER, BC, July 23, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (“BioVaxys” or the “Company”) announces that it intends to complete a non-brokered private placement (the “Private Placement”) consisting of up to 10,000,000 units (“Units”) at a…